I don't know the numbers but I'm not sure using 2008 data gives a fair picture. If the ROA of Barclays would have been consistently so much lower than that of GSK, the capital would simply gradually move to GSK. Banks are not allowed to borrow money, their creditors want to lend them money. (Presumably because TBTF lending is perceived to be a safer business than risky development of pharmaceuticals.)